The 169-acresite offers API manufacturing for oligonucleotides, peptides & conjugates from preclinical to commercial manufacturing.
Currently, the Taixing site just opened a new peptide plant that has 12,000 L total solid phase peptide synthesis reactor volume. To meet the growing customer needs, we plan to add more peptide manufacturing capacities soon.
When combining the peptide capacity in our Changzhou site, the total reactor volume of solid-phase peptide synthesizers at WuXi TIDES has reach over 32,000 L.
